Chemotherapy for elderly patients with advanced non-small-cell lung cancer: the Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase III randomized trial.

C, Gridelli; F, Perrone; C, Gallo; S, Cigolari; A, Rossi; F, Piantedosi; S, Barbera; F, Ferraù; E, Piazza; F, Rosetti; M, Clerici; O, Bertetto; SF, Robbiati; L, Frontini; C, Sacco; F, Castiglione; A, Favaretto; S, Novello; MR, Migliorino; G, Gasparini; D, Galetta; RV, Iaffaioli; V, Gebbia

doi:10.1093/jnci/95.5.362

Public

Chemotherapy for elderly patients with advanced non-small-cell lung cancer: the Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase III randomized trial.

Shared by NobleBlocks on Mar 1, 2003 • 12:00 AM UTC

Authors:

Gridelli C

Perrone F

Gallo C

Abstract

<h4>Background</h4>Vinorelbine prolongs survival and improves quality of life in elderly patients with advanced non-small-cell lung cancer (NSCLC). Some studies have also suggested that gemcitabine is well tolerated and effective in such patients. We compared the effectiveness and toxicity of the co...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!